133 related articles for article (PubMed ID: 22541728)
21. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease.
Bardella MT; Elli L; De Matteis S; Floriani I; Torri V; Piodi L
Ann Med; 2009; 41(2):139-43. PubMed ID: 18777226
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
23. Defense mechanisms in inflammatory bowel disease.
Hyphantis TN; Triantafillidis JK; Pappa S; Mantas C; Kaltsouda A; Cherakakis P; Alamanos Y; Manousos ON; Mavreas VG
J Gastroenterol; 2005 Jan; 40(1):24-30. PubMed ID: 15692786
[TBL] [Abstract][Full Text] [Related]
24. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
[TBL] [Abstract][Full Text] [Related]
25. [Neurological complications of inflammatory intestinal diseases].
Dietrich W; Erbguth F
Fortschr Neurol Psychiatr; 2003 Aug; 71(8):406-14. PubMed ID: 12910446
[TBL] [Abstract][Full Text] [Related]
26. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G
Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
Ghosh N; Chaki R; Mandal V; Lin GD; Mandal SC
Int Rev Immunol; 2010; 29(1):4-37. PubMed ID: 20100080
[TBL] [Abstract][Full Text] [Related]
28. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
[TBL] [Abstract][Full Text] [Related]
29. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of inflammatory bowel disease.
Lashner BA
Gastroenterol Clin North Am; 1995 Sep; 24(3):467-74. PubMed ID: 8809231
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study.
Casella G; D'Incà R; Oliva L; Daperno M; Saladino V; Zoli G; Annese V; Fries W; Cortellezzi C;
Dig Liver Dis; 2010 Mar; 42(3):175-8. PubMed ID: 19786375
[TBL] [Abstract][Full Text] [Related]
32. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of inflammatory bowel disease in patients with airways disease.
Raj AA; Birring SS; Green R; Grant A; de Caestecker J; Pavord ID
Respir Med; 2008 May; 102(5):780-5. PubMed ID: 18321696
[TBL] [Abstract][Full Text] [Related]
34. [The eye and chronic inflammatory diseases of the intestines. Immunopathological and genetic aspects. Apropos of 3 cases].
Raby O; Salvanet-Bouccara A; Forestier F
J Fr Ophtalmol; 1987; 10(11):683-98. PubMed ID: 3329203
[TBL] [Abstract][Full Text] [Related]
35. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
36. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Brand S
Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
[TBL] [Abstract][Full Text] [Related]
37. Emerging immunological targets in inflammatory bowel disease.
Monteleone G; Pallone F; MacDonald TT
Curr Opin Pharmacol; 2011 Dec; 11(6):640-5. PubMed ID: 22000933
[TBL] [Abstract][Full Text] [Related]
38. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease.
Probert CS; Chott A; Turner JR; Saubermann LJ; Stevens AC; Bodinaku K; Elson CO; Balk SP; Blumberg RS
J Immunol; 1996 Oct; 157(7):3183-91. PubMed ID: 8816432
[TBL] [Abstract][Full Text] [Related]
39. The genetic basis of inflammatory bowel disease.
Cooney R; Jewell D
Dig Dis; 2009; 27(4):428-42. PubMed ID: 19897957
[TBL] [Abstract][Full Text] [Related]
40. Immune mechanisms in chronic inflammatory bowel disease.
Braegger CP; MacDonald TT
Ann Allergy; 1994 Feb; 72(2):135-41. PubMed ID: 8109803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
